Evidence map›Paper›PMID 34677352›Full record

ReviewBiosensors2021

Malignancies and Biosensors: A Focus on Oral Cancer Detection through Salivary Biomarkers.

Riccardo Goldoni, Alessandra Scolaro, Elisa Boccalari, Carolina Dolci, Antonio Scarano, Francesco Inchingolo, Paolo Ravazzani, Paola Muti, Gianluca Tartaglia

Open access · goldAbstract readReview
In one paragraph

Review in Biosensors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Integrating Salivary Biomarkers CST4 andClinical Medicine Insights. Oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Riccardo GoldoniDepartment of Biomedical, Surgical and Dental Sciences, School of Dentistry, University of Milan, 20122 Milano, Italy.ORCID 0000-0002-5821-6248
Alessandra ScolaroDepartment of Biomedical, Surgical and Dental Sciences, School of Dentistry, University of Milan, 20122 Milano, Italy.
Elisa BoccalariDepartment of Biomedical, Surgical and Dental Sciences, School of Dentistry, University of Milan, 20122 Milano, Italy.
Carolina DolciDepartment of Biomedical, Surgical and Dental Sciences, School of Dentistry, University of Milan, 20122 Milano, Italy.
Antonio ScaranoDepartment of Innovative Technologies in Medicine & Dentistry, University of Chieti-Pescara, 66100 Chieti, Italy.
Francesco InchingoloDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, Italy.ORCID 0000-0003-3797-5883
Paolo RavazzaniNational Research Council, Institute of Electronics, Computer and Telecommunication Engineering (CNR IEIIT), 20133 Milano, Italy.ORCID 0000-0003-0282-3329
Paola MutiDepartment of Biomedical, Surgical and Dental Sciences, School of Dentistry, University of Milan, 20122 Milano, Italy.
Gianluca TartagliaDepartment of Biomedical, Surgical and Dental Sciences, School of Dentistry, University of Milan, 20122 Milano, Italy.
University of Milan · ITInstitute of Electronics, Computer and Telecommunication Engineering · ITUniversity of Bari Aldo Moro · ITUniversity of Chieti-Pescara · IT

Funding

Department of Biomedical, Surgical and Dental Sciences of Università di Milano PSR2020_DIP_017
6 · The paper itself

Abstract

Oral cancer is among the deadliest types of malignancy due to the late stage at which it is usually diagnosed, leaving the patient with an average five-year survival rate of less than 50%. The booming field of biosensing and point of care diagnostics can, in this regard, play a major role in the early detection of oral cancer. Saliva is gaining interest as an alternative biofluid for non-invasive diagnostics, and many salivary biomarkers of oral cancer have been proposed. While these findings are promising for the application of salivaomics tools in routine practice, studies on larger cohorts are still needed for clinical validation. This review aims to summarize the most recent development in the field of biosensing related to the detection of salivary biomarkers commonly associated with oral cancer. An introduction to oral cancer diagnosis, prognosis and treatment is given to define the clinical problem clearly, then saliva as an alternative biofluid is presented, along with its advantages, disadvantages, and collection procedures. Finally, a brief paragraph on the most promising salivary biomarkers introduces the sensing technologies commonly exploited to detect oral cancer markers in saliva. Hence this review provides a comprehensive overview of both the clinical and technological advantages and challenges associated with oral cancer detection through salivary biomarkers.

Indexed as

Biosensing TechniquesMouth NeoplasmsBiomarkers, TumorHumansSalivaBiomarkers, Tumorbiomarkersbiosensorsoral cancerpoint of care diagnosticssalivawearable devices

Identifiers

PMID34677352
PMCPMC8533918
OpenAlexW3205882577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.